Clinical Trial: Safety, Tolerability, and Pharmacokinetic Evaluations of CKR-051 After Transdermal Administration in Healthy Male Subjects
Study Status: COMPLETED
Recruit Status: COMPLETED
Condition: Healthy
Study Type: INTERVENTIONAL
Official Title: A Randomized, Single-blind, Placebo-controlled, Single/Multiple Dose, Dose Escalation, Phase 1 Clinical Trial to Evaluate Safety, Tolerability and Pharmacokinetic Characteristics of CKR-051 After
Brief Summary:
This study will evaluate the safety, tolerability, and pharmacokinetics (PK) of CKR-051 in healthy participants.This study aiming to develop an agent for skin regeneration; potential treatments include acute and chronic wounds (c.f.Diabetic foot ulcers).
Read more